The human iPSC line LEIi006-A was generated from dermal fibroblasts from a patient with retinitis pigmentosa using episomal plasmids containing OCT4, SOX2, KLF4, L-MYC, LIN28, mir302/367 microRNA and shRNA for p53. The iPSC cells carry compound heterozygous mutations (c.1892A > G and c.2548G > A) in the CRB1 gene. LEIi006-A expressed pluripotent stem cell markers, had a normal karyotype and could be differentiated into endoderm, mesoderm and ectodermal lineages, as well as retinal organoids.
Pubmed ID: 30092450 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This polyclonal targets IgG (H+L)
View all literature mentionsThis unknown targets Mouse IgG (H+L)
View all literature mentionsThis monoclonal targets PAX6
View all literature mentionsThis monoclonal targets Rhodopsin antibody [Rho 4D2]
View all literature mentionsThis monoclonal targets N-cadherin
View all literature mentionsThis monoclonal targets SSEA-4
View all literature mentionsThis polyclonal targets Nanog
View all literature mentionsThis monoclonal targets KLF4
View all literature mentionsThis unknown targets SOX2
View all literature mentionsThis monoclonal targets Oct-3/4
View all literature mentions